These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1418090)

  • 1. Apolipoprotein A-I and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP).
    Koren E; Armstrong VW; Mueller G; Wilson PR; Schuff-Werner P; Thiery J; Eisenhauer T; Alaupovic P; Seidel D
    Atherosclerosis; 1992 Aug; 95(2-3):157-70. PubMed ID: 1418090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO
    Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The concept of apolipoprotein-defined lipoprotein families and its clinical significance.
    Alaupovic P
    Curr Atheroscler Rep; 2003 Nov; 5(6):459-67. PubMed ID: 14525679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin extracorporeal LDL precipitation (HELP): an effective apheresis procedure for lowering Lp(a) levels.
    Armstrong VW; Schuff-Werner P; Eisenhauer T; Helmhold M; Stix M; Seidel D
    Chem Phys Lipids; 1994 Jan; 67-68():315-21. PubMed ID: 8187229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) and apolipoprotein(a) in a New World monkey, the common marmoset (Callithrix jacchus). Association of variable plasma lipoprotein(a) levels with a single apolipoprotein(a) isoform.
    Guo HC; Michel JB; Blouquit Y; Chapman MJ
    Arterioscler Thromb; 1991; 11(4):1030-41. PubMed ID: 1829630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of apolipoprotein E on cholesteryl ester-enriched low density lipoprotein particles in coronary artery atherosclerosis of hypercholesterolemic nonhuman primates.
    Stevenson SC; Sawyer JK; Rudel LL
    Arterioscler Thromb; 1992 Jan; 12(1):28-40. PubMed ID: 1731856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein heterogeneity and its effect on apolipoprotein assays.
    Fruchart JC
    Scand J Clin Lab Invest Suppl; 1990; 198():51-7. PubMed ID: 2111936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
    Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
    Genest JJ; Bard JM; Fruchart JC; Ordovas JM; Wilson PF; Schaefer EJ
    Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein B37, a naturally occurring lipoprotein containing the amino-terminal portion of apolipoprotein B100, does not bind to the apolipoprotein B,E (low density lipoprotein) receptor.
    Young SG; Peralta FP; Dubois BW; Curtiss LK; Boyles JK; Witztum JL
    J Biol Chem; 1987 Dec; 262(34):16604-11. PubMed ID: 3680266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
    Koren E; Corder C; Mueller G; Centurion H; Hallum G; Fesmire J; McConathy WD; Alaupovic P
    Atherosclerosis; 1996 Apr; 122(1):105-15. PubMed ID: 8724117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes.
    Igau B; Lestavel S; Clavey V; Slomianny C; Drouin P; Bresson R; Fruchart JC; Duriez P; Fiévet C
    Atherosclerosis; 1996 Feb; 120(1-2):209-19. PubMed ID: 8645362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesteryl ester transfer protein promotes the association of HDL apolipoproteins A-I and A-II with LDL: potentiation by oleic acid.
    Lagrost L; Barter PJ
    Biochim Biophys Acta; 1992 Aug; 1127(3):255-62. PubMed ID: 1511003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precipitation procedures used to isolate high density lipoprotein with particular reference to effects on apo A-I-only particles and lipoprotein(a).
    Vallance DT; Byrne DJ; Winder AF
    Clin Chim Acta; 1994 Sep; 229(1-2):77-85. PubMed ID: 7988057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B.
    Zawadzki Z; Tercé F; Seman LJ; Theolis RT; Breckenridge WC; Milne RW; Marcel YL
    Biochemistry; 1988 Nov; 27(22):8474-81. PubMed ID: 2468359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvastatin reduces levels of plasma apo B-containing particles and increases those of LpA-I. European Fluvastatin Study Group.
    Dallongeville J; Fruchart JC; Pfister P; Bard JM
    Am J Med; 1994 Jun; 96(6A):32S-36S. PubMed ID: 8017464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.